Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference
Baxter International (NYSE:BAX), a global medtech leader, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's chair, president and chief executive officer, José (Joe) E. Almeida, will deliver a presentation on Monday, January 13, 2025, at 10:30 a.m. Pacific Time. Interested parties can access the live webcast through www.baxter.com, with replay availability extending until July 12, 2025.
Baxter International (NYSE:BAX), un leader globale nel settore della tecnologia medica, ha annunciato la sua partecipazione al 43° Annuale J.P. Morgan Healthcare Conference. Il presidente, amministratore delegato e CEO dell'azienda, José (Joe) E. Almeida, terrà una presentazione lunedì 13 gennaio 2025, alle 10:30 a.m. Pacific Time. Le parti interessate possono accedere alla diretta streaming attraverso www.baxter.com, con disponibilità di replay fino al 12 luglio 2025.
Baxter International (NYSE:BAX), un líder global en tecnología médica, ha anunciado su participación en la 43ª Conferencia Anual de Atención Médica de J.P. Morgan. El presidente, director y CEO de la empresa, José (Joe) E. Almeida, ofrecerá una presentación el lunes 13 de enero de 2025, a las 10:30 a.m. Hora del Pacífico. Las partes interesadas pueden acceder a la transmisión en vivo a través de www.baxter.com, con disponibilidad de repetición hasta el 12 de julio de 2025.
배서 인터내셔널 (NYSE:BAX), 글로벌 의료 기술 리더가 제43회 JP 모건 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 의장, 사장 겸 CEO인 José (Joe) E. Almeida는 2025년 1월 13일 월요일 오전 10시 30분 (태평양 시간)에 발표를 진행할 예정입니다. 관심 있는 당사자는 www.baxter.com을 통해 생중계에 접속할 수 있으며, 다시 보기 가능 기간은 2025년 7월 12일까지 연장됩니다.
Baxter International (NYSE:BAX), un leader mondial de la technologie médicale, a annoncé sa participation à la 43ème Conférence Annuelle de Santé J.P. Morgan. Le président, directeur et PDG de l'entreprise, José (Joe) E. Almeida, fera une présentation le lundi 13 janvier 2025, à 10h30 heure du Pacifique. Les parties intéressées peuvent accéder à la diffusion en direct via www.baxter.com, avec la possibilité de revoir jusqu'au 12 juillet 2025.
Baxter International (NYSE:BAX), ein globaler Marktführer im Bereich Medizintechnik, hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz angekündigt. Der Vorsitzende, Präsident und CEO des Unternehmens, José (Joe) E. Almeida, wird am Montag, den 13. Januar 2025, um 10:30 Uhr pazifischer Zeit eine Präsentation halten. Interessierte Parteien können über www.baxter.com auf den Live-Stream zugreifen, mit der Möglichkeit, die Aufzeichnung bis zum 12. Juli 2025 anzusehen.
- None.
- None.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Saturday, July 12, 2025.
About Baxter
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241218540942/en/
Media Contact
Steve Brett, (224) 948-5353
media@baxter.com
Investor Contact
Clare Trachtman, (224) 948-3020
Source: Baxter International Inc.
FAQ
When is Baxter (BAX) presenting at the 2025 J.P. Morgan Healthcare Conference?
How long will the BAX J.P. Morgan Healthcare Conference presentation replay be available?
Who will represent BAX at the 2025 J.P. Morgan Healthcare Conference?
Where can investors watch Baxter's (BAX) J.P. Morgan Healthcare Conference presentation?
